KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Work In Process (2021 - 2025)

Historic Work In Process for Bionano Genomics (BNGO) over the last 5 years, with Q3 2025 value amounting to $388000.0.

  • Bionano Genomics' Work In Process fell 8917.11% to $388000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $388000.0, marking a year-over-year decrease of 8917.11%. This contributed to the annual value of $2.3 million for FY2024, which is 7600.61% down from last year.
  • Latest data reveals that Bionano Genomics reported Work In Process of $388000.0 as of Q3 2025, which was down 8917.11% from $653000.0 recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Work In Process registered a high of $10.6 million during Q2 2023, and its lowest value of $388000.0 during Q3 2025.
  • Moreover, its 5-year median value for Work In Process was $5.8 million (2022), whereas its average is $5.6 million.
  • As far as peak fluctuations go, Bionano Genomics' Work In Process skyrocketed by 32500.0% in 2022, and later plummeted by 8917.11% in 2025.
  • Quarter analysis of 5 years shows Bionano Genomics' Work In Process stood at $1.7 million in 2021, then skyrocketed by 325.0% to $7.1 million in 2022, then soared by 38.77% to $9.8 million in 2023, then plummeted by 76.01% to $2.3 million in 2024, then plummeted by 83.48% to $388000.0 in 2025.
  • Its Work In Process stands at $388000.0 for Q3 2025, versus $653000.0 for Q2 2025 and $1.6 million for Q1 2025.